Related references
Note: Only part of the references are listed.Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis
Kevin B. Boylan et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression
R. Tortelli et al.
EUROPEAN JOURNAL OF NEUROLOGY (2012)
Neurofilaments as biomarkers in multiple sclerosis
Charlotte E. Teunissen et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
The Neurofilament Light Chain is Not Stable in Vitro
Marleen J. A. Koel-Simmelink et al.
ANNALS OF NEUROLOGY (2011)
A method to solubilise protein aggregates for immunoassay quantification which overcomes the neurofilament hook effect
Ching-Hua Lu et al.
JOURNAL OF NEUROSCIENCE METHODS (2011)
Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis
J. Kuhle et al.
NEUROLOGY (2011)
Evidence for Acute Neurotoxicity after Chemotherapy
Axel Petzold et al.
ANNALS OF NEUROLOGY (2010)
A highly sensitive electrochemiluminescence immunoassay for the neurofilament heavy chain protein
Jens Kuhle et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
EFNS guidelines on disease-specific CSF investigations
F. Deisenhammer et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis
C. E. Teunissen et al.
NEUROLOGY (2009)
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
C. E. Teunissen et al.
NEUROLOGY (2009)
Diagnostic criteria for multiple sclerosis: 2005 Revisions to the McDonald Criteria
CH Polman et al.
ANNALS OF NEUROLOGY (2005)
Neurofilament phosphoforms: Surrogate markers for axonal injury, degeneration and loss
A Petzold
JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)
An enzyme immunoassay to quantify neurofilament light chain in cerebrospinal fluid
WJA Van Geel et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2005)
Biological markers in CSF and blood for axonal degeneration in multiple sclerosis
CE Teunissen et al.
LANCET NEUROLOGY (2005)
Axonal degeneration and inflammation in acute optic neuritis
A Petzold et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2004)
Neurofilament and glial fibrillary acidic protein in multiple sclerosis
N Norgren et al.
NEUROLOGY (2004)
Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS
C Malmeström et al.
NEUROLOGY (2003)
Elevated neurofilament levels in neurological
N Norgren et al.
BRAIN RESEARCH (2003)
A specific ELISA for measuring neurofilament heavy chain phosphoforms
A Petzold et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2003)
Monoclonal antibodies selective for low molecular weight neurofilaments
N Norgren et al.
HYBRIDOMA AND HYBRIDOMICS (2002)
Heightened intrathecal release of axonal cytoskeletal proteins in multiple sclerosis is associated with progressive disease and clinical disability
YK Semra et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences
C Bjartmar et al.
CURRENT OPINION IN NEUROLOGY (2001)
Share Paper
